FDAnews
www.fdanews.com/articles/178044-fda-grants-approval-to-gavis-pharmaceuticals-generic-potassium-chloride-er-capsules

FDA Grants Approval to Gavis Pharmaceuticals’ Generic Potassium Chloride ER Capsules

August 18, 2016

The FDA has green-lighted Gavis Pharmaceutical’s generic version of Actavis’ potassium chloride extended-release capsules.

Indian drugmaker Pharma Major Lupin, the parent company of Gavis, announced the FDA approval to market 600 mg and 750 mg capsules.

The generic is indicated for patients with potassium deficiencies in the bloodstream.

View today's stories